14
Participants
Start Date
March 2, 2020
Primary Completion Date
August 29, 2020
Study Completion Date
December 7, 2020
Rosuvastatin
Single dose of 5 mg rosuvastatin is administered as tablet orally on Day 1 of Period 1 (total length = 5 days).
Rosuvastatin + BAY1817080
A single dose of 5 mg rosuvastatin tablets is administered on Day 8 of Period 2 (total length = 15 days). BAY1817080 is administered as tablets twice daily on Days 1 to 14 of Period 2.
Covance Clinical Research Unit, Inc., Daytona Beach
Lead Sponsor
Bayer
INDUSTRY